A open label, randomized, controled trial to assess the utility of Pitavastatin for patients with type2 diabetes and obesity in Matsuyama Shimin Hospital.
Not Applicable
Recruiting
- Conditions
- Type 2 diabetic patients with hyperlipidemia
- Registration Number
- JPRN-UMIN000007024
- Lead Sponsor
- MATSUYAMA SHIMIN HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with insulin. 2) Patients requiring hospitalization to attain glycemic control. 3) Patients who have hypersensitivity to LIVALO tablet. 4) Patients who have severe liver dysfunction or biliary atresia. 5)Patients who are being treated with cyclosporine. 6) Pregnant women, women suspected of being pregnant, or lactating women. 7) Patients judged inadequate to participate in this study by their physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change about HbA1c
- Secondary Outcome Measures
Name Time Method 1)change in following laboratory data 1.fasting Glucose 2.HOMA-IR 3.adiponectin 4.hs-CRP 5.visceral fat,hepatic CT 6.AST,ALT 7.serum lipids (TC,LDL-C,HDL-C,TG) 8.Apoprotein (ApoA-1,ApoB,ApoE) 2) Relationship of following laboratory data 1. Relationship of change about HbA1c and change about each laboratory data 2. Relationship BMI and change about each laboratory data 3. Relationship of change about serum lipids(LDL-C,HDL-C,TG),Apoprotein(ApoA-1,ApoB,ApoE)and change about each laboratory data 4. Relationship of change about ALT,AST and change about each laboratory data 5. Relationship of change about visceral fat,hepatic CT and change about each laboratory data